Cargando…
Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells
[Image: see text] Cancer is the most severe disease worldwide. Every year, tens of millions of people are diagnosed with cancer, and over half of those people will ultimately die from the disease. Hence, the discovery of new inhibitors for fighting cancer is necessary. As a result, new indolyl-triaz...
Autores principales: | Youssef, Mohamed F., Nafie, Mohamed S., Salama, Eid E., Boraei, Ahmed T.A., Gad, Emad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753112/ https://www.ncbi.nlm.nih.gov/pubmed/36530255 http://dx.doi.org/10.1021/acsomega.2c06531 |
Ejemplares similares
-
Regioselectivity of the alkylation of S-substituted 1,2,4-triazoles with dihaloalkanes
por: Boraei, Ahmed T. A., et al.
Publicado: (2016) -
Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition
por: Thabet, Fatma M., et al.
Publicado: (2022) -
Study on the Fluorescent Activity of N(2)-Indolyl-1,2,3-triazole
por: Zhang, You-Can, et al.
Publicado: (2017) -
Synthesis of a New Series of Nitrogen/Sulfur Heterocycles by Linking Four Rings: Indole; 1,2,4-Triazole; Pyridazine; and Quinoxaline
por: Boraei, Ahmed T. A., et al.
Publicado: (2020) -
Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked Bis-Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K
por: Yakkala, Prasanna A., et al.
Publicado: (2022)